StockData
TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (TXMD) income statement

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3029% below fair value
$1.81+0.00 (0.00%)

Close on Nov 19, 2026Market cap $20.95MP/E –Yield –

See a number that looks wrong?